Table 1  Clinical characteristics of patients treated with continuous renal replacement using a cellulose triacetate filter

Age

years, mean (SD)

61.6 (9.5)

Male

n (%)

5 (71.4)

Acute kidney injury stage

n (%)

Stage 1

2 (28.6)

Stage 2

3 (42.9)

Stage 3

2 (28.6)

Hemofilter

n (%)

UT-2100S

6 (85.7)

UT-1100S

1 (14.3)

Anticoagulant

n (%)

Nafamostat mesylate

6 (85.7)

Heparin

1 (14.3)

Therapy onset post admission

h, median (IQR)

7 (5–89)

Dosage

mL/kg/h, median (IQR)

1000 (1000–2000)

Duration

days, median (IQR)

7 (6–9)

Circuit change

times/day, median (IQR)

1.0 (0.5–1.5)

with ECMO

n (%)

5 (71.4)

Outcome

n (%)

Survived

4 (57.1)